ANVS: Annovis Bio Company Short-Term Debt

Official company branding of annovisbio.com (ANVS)

Annovis Bio, Inc. (ANVS) maintains high profit potential based on its ownership of unique formulas. Short-term borrowings with maturities of up to one year demonstrate the current level of financial activity, where 0.00 shows the current value of the metric. Growth prospects rely on the expansion of buntanetap in Alzheimer's therapy, while the readiness of production facilities and laboratories guarantees the efficient launch of mass drug production.

ANVS (Annovis Bio) Company Short-Term Debts history from 07/04/2022 to 10/31/2026

Financial and market metric breakdowns for Annovis Bio Corporation (ANVS)

- current quotes and average value forecast:
Price Chart Annovis Bio|ANVS - Fair Value Consensus
- market capitalization information:
Market Value Annovis Bio, Inc.|ANVS - Total Enterprise Value
- shareholders' equity book value data:
Book Value per Share Annovis Bio|ANVS - Book Capitalization|Market Value to Book Value Ratio annovisbio.com|ANVS - Total Business Assets
- debt and liquidity details:
Debt to Equity Annovis Bio, Inc.|ANVS - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Annovis Bio, Inc.|ANVS - Company Cumulative Debt|Debt to Book Value Annovis Bio, Inc.|ANVS - Company Long-Term Debt|Company Short-Term Debts Annovis Bio|Quick Liquidity annovisbio.com
- net income and valuation multiples indicators:
ANVS - Net Financial Result
Basic company analysis:Annovis Bio - ANVS
Mass-produced product of Annovis Bio, Inc.

The innovative potential of Annovis Bio, Inc. (ANVS) in Alzheimer's therapy requires stable funding; however, geopolitical instability and the disruption of reagent supply chains could increase reliance on debt capital. By analyzing the volume of short-term liabilities, an investor assesses the aggregate of all obligations maturing within one year, which allows for the determination of the company's current liquidity and resilience to external shocks when planning investments.

Competitor analysis for Annovis Bio, Inc.

BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|ACAD (ACADIA Pharmaceuticals) - Company Short-Term Debts|Company Short-Term Debts xenon-pharma.com|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|Supernus Pharmaceuticals, Inc. - Company Short-Term Indebtedness|Company Short-Term Debt Catalyst Pharmaceuticals Inc CPRX|DNLI: Company Short-Term Indebtedness|HRMY - Company Short-Term Debt|Short-Term Debt biohavenpharma.com|AMLX (Amylyx Pharmaceuticals, Inc.) - Company Current Liabilities|TRVI (Trevi Therapeutics Inc) - Company Short-Term Debt|PRAX (Praxis Medicines) - Company Short-Term Debts|Anavex Life Sciences Corp (AVXL) - Short-Term Debt Volume|Company Short-Term Debt CeriBell, Inc. (CBLL)|Short-Term Debt Volume Prothena Corporation plc|Alector - Company Current Liabilities|Company Short-Term Loans and Borrowings ANNX|Omeros Corp. - Company Short-Term Debts|NGNE: Company Short-Term Debt|ACIU: Company Short-Term Debts|VYGR - Short-Term Debt Volume|Company Short-Term Debt Neumora Therapeutics, Inc.|Short-Term Debt Scilex Holding SCLX|Company Current Liabilities TVGN (Tevogen Bio Holdings, Inc.)|ACOG (alphacognition.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CGTX (Cognition Therapeutics, Inc.)|Short-Term Debt Volume inhibikase.com (IKT)|SAVA - Company Short-Term Debt|ASRT (Assertio Holdings, Inc.) - Company Short-Term Indebtedness|COYA: Company Short-Term Debts|Company Current Liabilities Vistagen|Company Current Liabilities OVID|acumenpharm.com (ABOS) - Short-Term Debt Volume|Company Short-Term Debts CRVO|Company Short-Term Debts alteritytherapeutics.com (ATHE)|Company Short-Term Debt Clene CLNN|PEPG: Company Short-Term Indebtedness|JUNS: Company Current Liabilities|RLMD: Company Short-Term Debt|gracetx.com (GRCE) - Company Short-Term Debt|AIFF - Short-Term Debt Volume|Company Short-Term Debt ANEW Medical|Company Short-Term Indebtedness NRSN (NeuroSense Therapeutics, Ltd.)|Company Short-Term Debts RVPH|MTVA - Short-Term Debt|NeurAxis - Company Current Liabilities|Company Short-Term Debts Helius Medical Technologies, Inc. HSDT|PASG - Company Short-Term Debt|Company Short-Term Loans and Borrowings NEUP (Neuphoria Therapeutics Inc.)|Minerva Neurosciences (NERV) - Company Short-Term Debt|Short-Term Debt athira.com (ATHA)|ADXN (Addex Therapeutics Ltd) - Company Short-Term Debts|Company Short-Term Debts Alzamend|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|protagenic.com - Company Short-Term Indebtedness|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|CRGT: Company Short-Term Indebtedness|ATXI - Company Short-Term Debt|Short-Term Debt Brainstorm Cell Therapeutics Inc.|CARA (Cara Therapeutics, Inc) - Company Current Liabilities|CHRO (Chromocell) - Company Short-Term Debt|ELYM (Eliem Therapeutics, Inc.) - Company Short-Term Debts|Intra-Cellular (ITCI) - Short-Term Debt Volume|Company Short-Term Debt Longboard Pharmaceuticals, Inc. (LBPH)|Short-Term Debt Volume Marinus Pharmaceuticals Inc|NKGen - Company Current Liabilities|Company Short-Term Loans and Borrowings NRBO|Sage Therapeutics, Inc. - Company Short-Term Debts|SNPX: Company Short-Term Debt|TRVN: Company Short-Term Debts|VIGL - Short-Term Debt Volume|Company Short-Term Debt Anew Medical, Inc.|Short-Term Debt Cerevel Corp CERE